Mannatech (NASDAQ:MTEX) Earns Buy Rating from Analysts at StockNews.com

Analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued to investors on Monday. The firm set a “buy” rating on the stock.

Mannatech Stock Down 1.2 %

NASDAQ:MTEX opened at $14.98 on Monday. The company’s fifty day moving average price is $10.63 and its 200-day moving average price is $8.55. The firm has a market capitalization of $28.24 million, a P/E ratio of -18.49 and a beta of 1.04. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. Mannatech has a 1-year low of $6.75 and a 1-year high of $15.83.

Mannatech (NASDAQ:MTEX) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%. The firm had revenue of $31.73 million during the quarter.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.